ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling

Interventions that alter cholesterol have differential impacts on hormone receptor positive- and negative-breast cancer risk and prognosis. This implies differential regulation or response to cholesterol within different breast cancer subtypes. We evaluated differences in side-chain hydroxycholester...

Descripción completa

Detalles Bibliográficos
Autores principales: Hutchinson, Samantha A, Lianto, Priscilia, Roberg-Larsen, Hanne, Battaglia, Sebastiano, Hughes, Thomas A, Thorne, James L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893441/
https://www.ncbi.nlm.nih.gov/pubmed/31683867
http://dx.doi.org/10.3390/nu11112618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893441/
https://www.ncbi.nlm.nih.gov/pubmed/31683867
http://dx.doi.org/10.3390/nu11112618

Ejemplares similares